| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |